These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. The prevalence of ocular complications in leprosy patients seen in the United Kingdom over a period of 21 years. Malik AN; Morris RW; Ffytche TJ Eye (Lond); 2011 Jun; 25(6):740-5. PubMed ID: 21423140 [TBL] [Abstract][Full Text] [Related]
25. Ocular findings in leprosy in the United States. Spaide R; Nattis R; Lipka A; D'Amico R Am J Ophthalmol; 1985 Sep; 100(3):411-6. PubMed ID: 4037027 [TBL] [Abstract][Full Text] [Related]
26. Ocular leprosy in West Malaysia. Search for a posterior segment lesion. Weerekoon L Br J Ophthalmol; 1972 Feb; 56(2):106-13. PubMed ID: 5010311 [No Abstract] [Full Text] [Related]
27. Ocular manifestations of leprosy. Dorman JE Lepr Rev; 1973 Dec; 44(4):216-9. PubMed ID: 4793800 [No Abstract] [Full Text] [Related]
28. Pattern and determinants of ocular complications in leprosy patients in eastern Nepal. Javvadhi S; Das H; Agrawal S Nepal J Ophthalmol; 2009; 1(1):2-8. PubMed ID: 21141014 [TBL] [Abstract][Full Text] [Related]
29. Ocular involvement in leprosy. Singhi MK; Kacchawa D; Ghiya BC Indian J Ophthalmol; 2002 Dec; 50(4):355-6. PubMed ID: 12532508 [No Abstract] [Full Text] [Related]
30. Defining the magnitude of ocular complications from leprosy: problems of methodology. Courtright PD Int J Lepr Other Mycobact Dis; 1988 Dec; 56(4):566-73. PubMed ID: 3221113 [TBL] [Abstract][Full Text] [Related]
31. Prevalence of ocular manifestations of leprosy in Port Moresby, Papua New Guinea. Dethlefs R Br J Ophthalmol; 1981 Apr; 65(4):223-5. PubMed ID: 7236564 [TBL] [Abstract][Full Text] [Related]
33. Eye disease in multibacillary leprosy patients at the time of their leprosy diagnosis: findings from the Longitudinal Study of Ocular Leprosy (LOSOL) in India, the Philippines and Ethiopia. Courtright P; Daniel E; Sundarrao ; Ravanes J; Mengistu F; Belachew M; Celloria RV; Ffytche T Lepr Rev; 2002 Sep; 73(3):225-38. PubMed ID: 12449887 [TBL] [Abstract][Full Text] [Related]
34. Is leprosy blindness avoidable? The effect of disease type, duration, and treatment on eye damage from leprosy in Uganda. Waddell KM; Saunderson PR Br J Ophthalmol; 1995 Mar; 79(3):250-6. PubMed ID: 7703204 [TBL] [Abstract][Full Text] [Related]
35. [Local application of promin in ocular manifestations of leprosy (preliminary note)]. Bouzas A Bull Mem Soc Fr Ophtalmol; 1966; 79():200-6. PubMed ID: 6015380 [No Abstract] [Full Text] [Related]
36. [Etiology of blindness in Chad]. Vedy J Med Trop (Mars); 1972; 32():Suppl:427-33. PubMed ID: 4641951 [No Abstract] [Full Text] [Related]
37. Longitudinal follow-up of eyes in leprosy. Rajan MA Indian J Lepr; 1998; 70(1):109-14. PubMed ID: 9598412 [No Abstract] [Full Text] [Related]
38. Eye diseases and blindness in Adjumani refugee settlement camps, Uganda. Kawuma M East Afr Med J; 2000 Nov; 77(11):580-2. PubMed ID: 12862101 [TBL] [Abstract][Full Text] [Related]
39. Clinico-histopathological study of the eye in leprosy. Mithal S; Pratap VK; Gupta A; Rajiv Indian J Ophthalmol; 1988; 36(3):135-9. PubMed ID: 3255704 [No Abstract] [Full Text] [Related]
40. Ocular leprosy in Kenya. Adala HS; Kagame K East Afr Med J; 1988 Sep; 65(9):593-601. PubMed ID: 3265663 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]